A Vero cell-based seasonal influenza vaccine candidate may be promising for immunogenicity across three seasonal influenza strains

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1599, 2007-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inactivated Split-Virion Seasonal Influenza Vaccine (Fluarix®): A Review of its Use in the Prevention of Seasonal Influenza in Adults and the Elderly

By Curran Monique P.  

Drugs, Vol. 70, Iss. 12, 2010-08 ,pp. : 1519-1543

Adis International

Access to resources Recommend Favorite

Live Attenuated Influenza Vaccine (Fluenz™): A Guide to its Use in the Prevention of Seasonal Influenza in Children in the EU

By Scott Lesley J.   Carter Natalie J.   Curran Monique P.  

Pediatric Drugs, Vol. 14, Iss. 4, 2012-08 ,pp. : 271-279

Adis International

Access to resources Recommend Favorite

Live Attenuated Influenza Vaccine (FluMist®; Fluenz™): A Review of its Use in the Prevention of Seasonal Influenza in Children and Adults

By Carter Natalie J.   Curran Monique P.  

Drugs, Vol. 71, Iss. 12, 2011-08 ,pp. : 1591-1622

Adis International

Access to resources Recommend Favorite

A/H5N1 Prepandemic Influenza Vaccine (Whole Virion, Vero Cell-Derived, Inactivated) [Vepacel®]

By Plosker Greg L.  

Drugs, Vol. 72, Iss. 11, 2012-07 ,pp. : 1543-1557

Adis International

Access to resources Recommend Favorite

Cell-Based Influenza Vaccines: Progress to Date

By Audsley Jennifer M.   Tannock Gregory A.  

Drugs, Vol. 68, Iss. 11, 2008-01 ,pp. : 1483-1491

Adis International

Access to resources Recommend Favorite